Detalhe da pesquisa
1.
Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
Br J Dermatol
; 189(5): 603-611, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409661
2.
Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.
Int J Mol Sci
; 23(3)2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163421
3.
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.
Int Arch Allergy Immunol
; 181(10): 733-745, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32690848
4.
CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.
Int J Mol Sci
; 21(24)2020 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333768
5.
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.
Blood
; 130(14): 1628-1638, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28830887
6.
Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy.
Int J Mol Sci
; 19(8)2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30071644
7.
Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.
Immunology
; 146(1): 173-83, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26094816
8.
B-cell receptor signaling in the pathogenesis of lymphoid malignancies.
Blood Cells Mol Dis
; 55(3): 255-65, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26227856
9.
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.
Nat Commun
; 15(1): 752, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272918
10.
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Oncoimmunology
; 13(1): 2362454, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38846084
11.
In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies.
Cancers (Basel)
; 15(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612228
12.
The "Magic Bullet" Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era.
Cells
; 10(6)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203935
13.
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome.
Oncoimmunology
; 10(1): 1873530, 2021 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33643690
14.
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.
Oncoimmunology
; 9(1): 1738797, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32760603
15.
Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors.
Oncol Lett
; 20(1): 533-540, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565979
16.
Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives.
Cancers (Basel)
; 11(10)2019 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554169
17.
Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome.
Leuk Lymphoma
; 60(8): 1899-1907, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30638415
18.
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.
Leukemia
; 33(10): 2416-2428, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30872780
19.
Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate.
Redox Biol
; 21: 101062, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576925
20.
FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy.
Oncoimmunology
; 7(5): e1423183, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721381